** Shares of the laboratory instrument services provider
TRNS.O rise as much as 5.94% to $50.29
** Co posts Q4 revenue of $48.8 mln, beating Refinitiv IBES
estimates of $46.2 mln, driven by sales in its service segment
** Distribution is expected to achieve high double-digit
growth in Q1 -TRNS
** Co also adds that for Q1 of fiscal 2022, it expects
service organic growth to be similar to what it achieved in Q4
** Co's Q4 service segment revenue grew 15.8% to $29.0 mln
from a year earlier
** Up to last close, stock UP ~44% YTD
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))